Canlyniadau Chwilio - Rohit Loomba

Mireinio'r Canlyniadau
  1. 1
    Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions

    Role of imaging-based biomarkers in NAFLD: Recent advances in clinical application and future research directions gan Rohit Loomba

    Cyhoeddwyd 2017
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers

    Nonalcoholic fatty liver disease: Indications for liver biopsy and noninvasive biomarkers gan Mazen Noureddin, Rohit Loomba

    Cyhoeddwyd 2012
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    The Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH

    The Hierarchical Model of NAFLD: Prognostic Significance of Histologic Features in NASH gan Rohit Loomba, Naga Chalasani

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Carta
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non‐alcoholic fatty liver disease

    Review article: the emerging interplay among the gastrointestinal tract, bile acids and incretins in the pathogenesis of diabetes and non‐alcoholic fatty liver disease gan Amir Zarrinpar, Rohit Loomba

    Cyhoeddwyd 2012
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions

    Hepatitis B Reactivation Associated With Immune Suppressive and Biological Modifier Therapies: Current Concepts, Management Strategies, and Future Directions gan Rohit Loomba, T. Jake Liang

    Cyhoeddwyd 2017
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications

    Review article: emerging role of the gut microbiome in the progression of nonalcoholic fatty liver disease and potential therapeutic implications gan Saumya Jayakumar, Rohit Loomba

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    PNPLA3 Genotype and Risk of Liver and All‐Cause Mortality

    PNPLA3 Genotype and Risk of Liver and All‐Cause Mortality gan Stefan Stender, Rohit Loomba

    Cyhoeddwyd 2020
    Cael y testun llawn
    Carta
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Imaging biomarkers of NAFLD, NASH, and fibrosis

    Imaging biomarkers of NAFLD, NASH, and fibrosis gan Veeral Ajmera, Rohit Loomba

    Cyhoeddwyd 2021
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Advances in the genetics of nonalcoholic fatty liver disease

    Advances in the genetics of nonalcoholic fatty liver disease gan Veeral Ajmera, Rohit Loomba

    Cyhoeddwyd 2023
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis

    Recommendations for Diagnosis, Referral for Liver Biopsy, and Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis gan Erin K. Spengler, Rohit Loomba

    Cyhoeddwyd 2015
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD

    Noninvasive imaging biomarker assessment of liver fibrosis by elastography in NAFLD gan Elliot B. Tapper, Rohit Loomba

    Cyhoeddwyd 2018
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis Caused by NASH

    The 20% Rule of NASH Progression: The Natural History of Advanced Fibrosis and Cirrhosis Caused by NASH gan Rohit Loomba, Leon A. Adams

    Cyhoeddwyd 2019
    Cael y testun llawn
    Carta
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Advances in non-invasive assessment of hepatic fibrosis

    Advances in non-invasive assessment of hepatic fibrosis gan Rohit Loomba, Leon A. Adams

    Cyhoeddwyd 2020
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC

    Emerging role of statin therapy in the prevention and management of cirrhosis, portal hypertension, and HCC gan Suzanne R. Sharpton, Rohit Loomba

    Cyhoeddwyd 2023
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Targeting Dysbiosis for the Treatment of Liver Disease

    Targeting Dysbiosis for the Treatment of Liver Disease gan Gobind Anand, Amir Zarrinpar, Rohit Loomba

    Cyhoeddwyd 2016
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease

    Advances in non-invasive biomarkers for the diagnosis and monitoring of non-alcoholic fatty liver disease gan Michelle T. Long, Sanil Gandhi, Rohit Loomba

    Cyhoeddwyd 2020
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk

    The Relationship Between Type 2 Diabetes, NAFLD, and Cardiovascular Risk gan Cyrielle Caussy, Adrien Aubin, Rohit Loomba

    Cyhoeddwyd 2021
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD

    Non-invasive methods for imaging hepatic steatosis and their clinical importance in NAFLD gan Nobuharu Tamaki, Veeral Ajmera, Rohit Loomba

    Cyhoeddwyd 2021
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction‐associated steatotic liver disease

    Implications of the new nomenclature of steatotic liver disease and definition of metabolic dysfunction‐associated steatotic liver disease gan Rohit Loomba, Vincent Wai‐Sun Wong

    Cyhoeddwyd 2023
    Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study

    Synergistic association between alcohol intake and body mass index with serum alanine and aspartate aminotransferase levels in older adults: the Rancho Bernardo Study gan Rohit Loomba, Ricki Bettencourt, E. Barrett-Connor

    Cyhoeddwyd 2009
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: